Krio ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 248 | Glucose transporter type 1 deficiency | 1 |
248. Glucose transporter type 1 deficiency
Clinical trials : 29 / Drugs : 9 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03202108 (ClinicalTrials.gov) | May 11, 2018 | 26/6/2017 | Evaluation of Krio in Children and Adults With Epilepsy | A Feasibility Study to Evaluate the Acceptability of Krio, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability | Ketogenic Dieting;Epilepsy;Glucose Transporter Type 1 Deficiency Syndrome | Dietary Supplement: Krio | Vitaflo International, Ltd | NULL | Withdrawn | 3 Years | N/A | All | 0 | N/A | United Kingdom |